ABBV vs CAH
By Alex · Tickerpine
AbbVie Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CAH |
|---|---|---|
| Price | $285.64 | $249.57 |
| Market cap | $504.76B | $57.79B |
| P/E ratio | 80.5 | 34.5 |
| ROE | — | — |
| Profit margin | 9.80% | 0.67% |
| Revenue growth | 10.20% | 5.80% |
| Dividend yield | 2.42% | 0.83% |
| Beta | 0.23 | 0.50 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CAH in plain English
- ABBV is the bigger company — about 8.7× the market cap of CAH.
- CAH is cheaper on earnings (P/E 34.5 vs 80.5).
- ABBV is growing revenue faster (10% vs 6%).
- ABBV has the higher dividend yield (2.42% vs 0.83%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.